Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2022

Nov 22, 2022

34472_dirs_2022-11-21_625a83a2-9bc0-46cd-b532-bf8885a1a0d1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2022-11-21

Reporting Person: PATIENCE JOHN (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-21 Common Stock P 1739130 $1.15 Acquired 4550483 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 337926 Direct
Common Stock 2078298 Indirect
Common Stock 52988 Indirect

Footnotes

F1: The reporting person is the sole trustee of John Patience Trust (July 23, 1993).

F2: The reporting person is the sole general partner of Patience Enterprises LP. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.